Diagnostic utility of combination of inducer and inhibitor based assay in detection of Pseudomonas aeruginosa producing AmpC β-lactamase

Journal of Microbiological Methods

Volumn 87, Issue 1, 2011, Pages 116-118

  Upadhyay, Supriya ^a   Sen, Malay Ranjan ^a   Bhattacharjee, Amitabha ^b   Prakash, Pradyot ^a   Bajpai, Ram Chandra ^a   Anupurba, Shampa ^a  

^a BANARAS HINDU UNIVERSITY   (India)

^b ASSAM UNIVERSITY   (India)

Author keywords

AmpC lactamases; Boronic acid; Inducer; Inhibitor; P. aeruginosa

Indexed keywords

AZTREONAM; BETA LACTAMASE AMPC; BORONIC ACID DERIVATIVE; CEFEPIME; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CLOXACILLIN; IMIPENEM; MEROPENEM; MONOBACTAM;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM DETECTION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISK DIFFUSION; DRUG ANTAGONISM; DRUG INHIBITION; ENZYME SYNTHESIS; ESCHERICHIA COLI; GENOTYPE; MICROBIOLOGICAL EXAMINATION; MINIMUM INHIBITORY CONCENTRATION; MODIFIED THREE DIMENSIONAL TEST; MULTIPLEX POLYMERASE CHAIN REACTION; NONHUMAN; PHENOTYPE; PREDICTIVE VALUE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RELIABILITY; SENSITIVITY AND SPECIFICITY;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; BORONIC ACIDS; CLOXACILLIN; GENE EXPRESSION REGULATION, BACTERIAL; GENOTYPE; HUMANS; MICROBIAL SENSITIVITY TESTS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

PSEUDOMONAS AERUGINOSA;

EID: 80052374263     PISSN: 01677012     EISSN: 18728359     Source Type: Journal    
DOI: 10.1016/j.mimet.2011.07.012     Document Type: Article

References (17)

1. Belkum A.V., Kluytmans J., et al. Multicenter evaluation of arbitrarily primed PCR for typing of Staphylococcus aureus strains. J. Clin. Microbiol. 1995, 33:1537-1547.
2. Cantarelli V.V., Inamine E., Brodt T.C.Z., Secchi C., Cavalcante B.C., Pereira F. Utility of ceftazidime-imipenem antagonism test (CIAT) to detect and confirm the presence of inducible AmpC beta lactamases among enterobacteriaceae. Braz. J. Infect. Dis. 2007, 11:237-239.
3. Carmeli Y., Troillet N., Eliopoulos G.M., Samore M.S. Emergence of antibiotic-resistant Pseudomonas aeruginosa: comparison of risk associated with different antipseudomonal agents. Antimicrob. Agents Chemother. 1999, 43:1379-1382.
4. Cavallo J.D., Fabre R., Leblanc F., Nicolas-Chanoine M.H., Thabaut A. Antibiotic susceptibility and mechanisms of beta-lactam resistance in 1310 strains of Pseudomonas aeruginosa: a French multicentre study (1996). J. Antimicrob. Chemother. 2000, 46:133-136.
5. CLSI Performance Standards for Antimicrobial Disc Susceptibility Tests 2005, M100-S15. CLSI, Wayne PA.
6. Colee J.G., Diguid J.P., Fraser A.G. Mackie and McCartney Practical Medical Microbiology 1996, (Churchill Livingstone Edinburgh). 14th ed.
7. Coudron P.E. Inhibitor based methods for detection of plasmid mediated AmpC beta lactamases in Klebsiella spp. Escherichia coli and Proteus mirabilis. J. Clin. Microbiol. 2005, 43:4163-4167.
8. Coudron P.E., Moland E.S., Thomson K.S. Occurrence and detection of AmpC beta lactamases among Escherichia coli, Klebsiella pneumonia and Proteus mirabilis isolates at a veterans medical center. J. Clin. Microbiol. 2000, 38:1791-1796.
9. Jacoby G.A. AmpC beta-lactamases. Clin. Microb. Rev. 2009, 22:161-182.
10. Juan C., Moyá B., Pérez J.L., Oliver A. Stepwise upregulation of the Pseudomonas aeruginosa chromosomal cephalosporinase conferring high-level beta-lactam resistance involves three AmpD homologues. Antimicrob. Agents Chemother. 2006, 50:1780-1787.
11. Livermore D.M. Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare?. Clin. Infect. Dis. 2002, 34:634-640.
12. Pérez-Pérez F.J., Hanson N.D. Detection of plasmid-mediated AmpC-lactamase genes in clinical isolates by using multiplex PCR. J. Clin. Microbiol. 2002, 40:2153-2162.
13. Sanders C.C., Sanders W.E., Goering R.V. In vitro antagonism of beta-lactam antibiotics by cefoxitin. Antimicrob. Agents Chemother. 1982, 21:968-975.
14. Schmidtke A.J., Hanson N.D. Role of ampD homologs in overproduction of AmpC in clinical isolates of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 2008, 52:3922-3927.
15. Tan T.Y., Ng L.S.Y., He J., Koh T.H., Hsu L.Y. Evaluation of screening methods to detect plasmid mediated AmpC in Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis. Antimicrob. Agents Chemother. 2009, 53:146-149.
16. Thomson K.S. Controversies about extended-spectrum and AmpC beta-lactamases. Emerg. Infect. Dis. 2001, 7:333-336.
17. Vincent J.L. Nosocomial infections in adult intensive-care units. Lancet 2003, 361:2068-2077.